Taking everything into account, REGN scores 1 out of 10 in our technical rating. REGN's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
When comparing the yearly performance of all stocks, REGN is a bad performer in the overall market: 86% of all stocks are doing better.
REGN is currently trading near the lower end of its 52 week range, which is not a good sign. The S&P500 Index is trading in the upper part of its 52 week range, so REGN is lagging the market.
In the last month REGN has a been trading in the 520.50 - 615.61 range, which is quite wide. It is currently trading in the middle of this range where prices have been consolidating recently, this may present a good entry opportunity, but some resistance may be present above.
REGN has an average volume of 1203320 traded shares per day. This is a good sign as it is always nice to have a liquid stock.
REGN is an average performer in the Biotechnology industry, it outperforms 60% of 562 stocks in the same industry.
Volume is considerably higher in the last couple of days.